REAL ESTATE ACQUISITION — ARMENIA — INBOUND FOREIGN INVESTMENT · PHARMACEUTICALS SECTOR
Client. A foreign investor in the pharmaceuticals sector seeking to acquire real property and establish land-use rights in Armenia for the purpose of constructing and operating a pharmaceutical production facility.
Background. Armenian land legislation imposes restrictions and procedural requirements on foreign persons and foreign-controlled entities acquiring real property and agricultural or industrial land rights. In the pharmaceuticals sector, a transaction of this nature involves an additional regulatory layer: sector-specific licensing requirements administered by Armenian health and pharmaceutical regulators interact with the land acquisition process, affecting the sequencing of corporate, property, and regulatory steps. The client required coordinated advice spanning Armenian real estate law, foreign investor land rights, and pharmaceutical sector regulation before committing capital to the acquisition.
Our role. Counsel coordinated the legal analysis across Armenian real estate law and the applicable pharmaceutical regulatory framework, advising the client on permissible acquisition structures for a foreign investor, the regulatory clearances required prior to or concurrent with the land rights registration, and the interaction between the acquisition timeline and the client's Armenian entity formation. The engagement involved close coordination with local Armenian counsel and drew on the firm's cross-border EAEU access practice to advise on the structuring dimension. For further guidance on Armenian regulatory and licensing matters, see the firm's Regulatory & Licensing — Armenia (/jurisdictions/armenia/regulatory-licensing/) practice page and the Armenia jurisdiction overview (/jurisdictions/armenia/).
Outcome. [PLACEHOLDER — operator to replace with real outcome]
[CTA: Discuss a similar matter — info@vetrovpartners.com | WhatsApp/Telegram: +7 (983) 510-38-76]